We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+9.23%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.22B
AUM Growth
+$2.7B
Cap. Flow
+$3.76B
Cap. Flow %
89.24%
Top 10 Hldgs %
40.53%
Holding
623
New
593
Increased
5
Reduced
1
Closed
3

Sector Composition

Rank Sector Weight
1 Financials 22.21%
2 Healthcare 21.36%
3 Technology 18.59%
4 Industrials 5.57%
5 Real Estate 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
451
Meta Platforms (Facebook)
META
$1.5T
$424K 0.01%
+2,000
New +$341K
FNA
452
DELISTED
Paragon 28, Inc.
FNA
$423K 0.01%
+24,800
New +$442K
PRAX icon
453
Praxis Precision Medicines
PRAX
$10.3B
$410K 0.01%
+33,817
New +$1.43M
M icon
454
PUT
Macy's
M
$6.61B
$410K 0.01%
+112,500
New +$2.38M
CHGG icon
455
Chegg
CHGG
$98.4M
$408K 0.01%
+25,000
New +$468K
TDC icon
456
Teradata
TDC
$2.51B
$403K 0.01%
+10,003
New +$372K
SYBX
457
DELISTED
Synlogic
SYBX
$402K 0.01%
+42,354
New +$503K
ELAN icon
458
Elanco Animal Health
ELAN
$12.1B
$395K 0.01%
+42,000
New +$495K
PRQR icon
459
ProQR Therapeutics
PRQR
$268M
$383K 0.01%
+180,000
New +$550K
DASH icon
460
DoorDash
DASH
$92.4B
$381K 0.01%
+6,000
New +$344K
XLF icon
461
PUT
State Street Financial Select Sector SPDR ETF
XLF
$58.4B
$381K 0.01%
+750,000
New +$26.1M
EIGR
462
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$379K 0.01%
+14,070
New +$654K
DAWN
463
DELISTED
Day One Biopharmaceuticals
DAWN
$375K 0.01%
+28,053
New +$548K
CTMX icon
464
CytomX Therapeutics
CTMX
$734M
$373K 0.01%
+247,157
New +$559K
CABA icon
465
Cabaletta Bio
CABA
$450M
$372K 0.01%
+45,000
New +$421K
EVLVW
466
DELISTED
Evolv Technologies Warrant
EVLVW
$372K 0.01%
+708,885
New +$343K
SYK icon
467
Stryker
SYK
$129B
$366K 0.01%
+1,283
New +$340K
ORTX
468
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$363K 0.01%
+67,512
New +$367K
NFLX icon
469
Netflix
NFLX
$307B
$357K 0.01%
+10,330
New +$342K
CYPH
470
Cypherpunk Technologies Inc
CYPH
$71.7M
$357K 0.01%
+104,869
New +$550K
UBX
471
DELISTED
Unity Biotechnology
UBX
$347K 0.01%
+213,040
New +$854K
ESPR
472
DELISTED
Esperion Therapeutics
ESPR
$328K 0.01%
+206,259
New +$1.06M
RVLP
473
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$315K 0.01%
+276,428
New +$332K
AKTS
474
DELISTED
Akoustis Technologies Inc
AKTS
$308K 0.01%
+100,000
New +$349K
CPRI icon
475
PUT
Capri Holdings
CPRI
$1.7B
$307K 0.01%
+18,200
New +$976K

Similar funds

UBS O'Connor's Q1 2023 Portfolio in Review

As of Q1 2023, UBS O'Connor held 623 positions worth $4.22B, up 177% from $1.52B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor deployed $3.76B of net new capital in Q1 2023, opening 593 new positions and adding to 5 existing holdings. Its largest new stake was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Activision Blizzard, an estimated $196M trimmed.

  • UBS O'Connor's largest Q1 2023 buy was Oak Street Health, Inc.: 6,537,297 shares worth $25.3M.
  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $189M increase.
  • UBS O'Connor's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $196M.
  • UBS O'Connor fully exited Signify Health, Inc. in Q1 2023, selling an estimated $161M.
  • UBS O'Connor's ten largest holdings make up 41% of its $4.22B portfolio in Q1 2023.
  • UBS O'Connor opened 593 new positions and closed 3 in Q1 2023.
  • UBS O'Connor's portfolio value rose 177% quarter-over-quarter to $4.22B.

Based on UBS O'Connor's 13F filing for Q1 2023, filed 15 May 2023.